Ibalizumab 71124-0024-00
- Manufacturer
- Samsung Biologics Co. Ltd
- Dosage Form
- Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- February 22, 2022
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ibalizumab | 200 mg/1 |
Selected Package
71124-0024-00Selected1 SOLUTION in 1 VIAL (71124-0024-0)